Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Explore strategies to prevent wasting your credit card benefits and maximize your rewards potential.
14,851 articlesA new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Choosing between a large-cap growth ETF like VONG and a small-cap growth ETF like SLYG can shape your risk and return...
Three Dow components traditionally labeled as old economy stocks have surged past the broader market, driven by durab...
Circle debuted CirBTC on Ethereum, a 1:1 BTC-backed ERC-20 token with real-time reserve proof, targeting institutiona...
Asset managers reevaluating security are treating safety features as a core lever to stabilize NOI and attract tenant...
In 2026, memory-chip names Micron and Sandisk have surged past Nvidia, reshaping the AI stock landscape. This article...
A wall street analyst thinks Viking Therapeutics could unlock substantial upside if VK2735 delivers in Phase 3. Learn...
medicare advantage’s premium comes with a catch that could affect coverage during serious illness. As enrollment tren...
Oracle's latest guidance sparked a sell-off as investors weigh AI-driven capital outlays against cash flow. This arti...
The latest pullback in software-as-a-service stocks may feel painful, but it also creates patient-buying opportunitie...
The cybersecurity talent gap is widening as AI skills grow faster than supply. A new market study shows hiring more s...
Coca-Cola climbed to a fresh 52-week high this week as earnings momentum and a World Cup sponsorship tailwind attract...